Research Topics
| Margaret R E McCredieSummaryAffiliation: University of Otago Country: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort studyMargaret R E McCredie
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
Lancet Oncol 9:425-34. 2008..We aimed to estimate the long-term risk of invasive cancer in these two groups of women. A judicial inquiry referred for independent clinical review in 1988 all women for whom there remained doubt about the adequacy of their management...- Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3Margaret R E McCredie
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
Aust N Z J Obstet Gynaecol 50:363-70. 2010..A comparison is made with women who were diagnosed earlier (1955-1964) and later (1975-1976)... 
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002John H Stewart
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
Nephrology (Carlton) 12:520-7. 2007....- Review of cytologic slides from the national women's hospital, New Zealand, cohort of women with cervical intraepithelial neoplasia 3 diagnosed in 1955-1976Margaret R E McCredie
Department of Preventive and Social Medicine, University of Otago, Dunedin New Zealand
Acta Cytol 50:632-6. 2006..To review cytologic slides, mostly at least 25 years old, from women attending National Women's Hospital, Auckland, who had been diagnosed histologically with cervical carcinoma in situ in 1955-1976... - The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002John H Stewart
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
Am J Kidney Dis 48:183-91. 2006..These between-population differences are not explained by community rates of hypertension or ascertainment bias... - Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New ZealandJohn H Stewart
Department of Medical and Surgical Sciences, University of Otago, Dunedin, New Zealand
J Am Soc Nephrol 14:197-207. 2003.... - The pattern of excess cancer in dialysis and transplantationJohn H Stewart
Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
Nephrol Dial Transplant 24:3225-31. 2009..The smaller excess of cancer in dialysis has been less well described, but two studies suggested that impaired immunity might be responsible... - Comparison of cancer mortality and incidence in New Zealand and AustraliaDavid C G Skegg
Department of Preventive and Social Medicine, University of Otago, Dunedin
N Z Med J 115:205-8. 2002..For a national cancer control strategy, it will be essential to clarify reasons for the high incidence of cancer and to study survival following treatment... - Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parametersBrett Delahunt
Department of Pathology, Wellington School of Medicine, University of Otago, Wellington, New Zealand
Cancer 94:658-64. 2002..This study investigates the prognostic significance of tumor size in a series of organ-confined clear cell renal cell carcinomas... - Cancer incidence before and after kidney transplantationClaire M Vajdic
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
JAMA 296:2823-31. 2006..Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed... - Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in AustraliaJohn H Stewart
Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia
Nephrology (Carlton) 9:238-46. 2004..CONCLUSION: Whether recent disease control measures have had an impact on incidence of treated ESRD is not yet certain, but seems more likely than implied by previous reports... - ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerGianluca Severi
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
J Natl Cancer Inst 95:818-24. 2003..In five of the seven total studies, subject selection was influenced by prostate-specific antigen (PSA) levels. We examined the association and possible effect of subject selection in a larger study and a meta-analysis... - Androgenetic alopecia and prostate cancer: findings from an Australian case-control studyGraham G Giles
Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Melbourne, VIC 3053 Australia
Cancer Epidemiol Biomarkers Prev 11:549-53. 2002..91 (1.59-5.32) for vertex baldness; and 1.95 (1.10-3.45) for frontal and vertex baldness. This association between the pattern of AA and prostate cancer points to shared androgen pathways that are worthy of additional investigation... - Is MSH2 a breast cancer susceptibility gene?Ee Ming Wong
Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne 3010, Australia
Fam Cancer 7:151-5. 2008..Extensive screening of 59 multiple-case breast cancer families did not identify any coding region mutations or larger genomic alterations in MSH2 that might implicate MSH2 as a breast cancer susceptibility gene... - The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous AustraliansJohn H Stewart
Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia
Nephrol Dial Transplant 19:678-85. 2004..CONCLUSIONS: The incidence and pattern of treated ESRD differs quantitatively and qualitatively between Maori, Pacific Island people and other New Zealanders, and Indigenous and non-indigenous Australians... - Increased incidence of squamous cell carcinoma of eye after kidney transplantationClaire M Vajdic
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2 376 Victoria St, Darlinghurst NSW 2010, Australia
J Natl Cancer Inst 99:1340-2. 2007..Our data also support an interaction between immune suppression and sun exposure in the development of ocular SCC after kidney transplantation... - A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer riskAmanda B Spurdle
Cancer and Cell Biology Division, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland, Australia
Cancer Epidemiol Biomarkers Prev 16:769-74. 2007.... - A common coding variant in CASP8 is associated with breast cancer riskAngela Cox
Sheffield University Medical School, Sheffield S10 2RX, UK
Nat Genet 39:352-8. 2007..02-1.13) and 1.16 (95% c.i.: 1.08-1.25), respectively; P(trend) = 2.8 x 10(-5)). These results demonstrate that common breast cancer susceptibility alleles with small effects on risk can be identified, given sufficiently powerful studies... - Prognosis of premenopausal breast cancer and childbirth prior to diagnosisKelly-Anne Phillips
Peter MacCallum Cancer Centre, University of Melbourne, Carlton, Victoria 3053, Australia
J Clin Oncol 22:699-705. 2004..Clinicians should be aware that women diagnosed with breast cancer within a few years following childbirth may have a worse outcome than that suggested solely by the standard histopathological prognostic factors of their cancer... - Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinomaDianne Sika-Paotonu
Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington, New Zealand
Am J Surg Pathol 30:1091-6. 2006.... - Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutationsGillian S Dite
Centre for Genetic Epidemiology, The University of Melbourne, Melbourne, Australia
J Natl Cancer Inst 95:448-57. 2003.... - Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based studyLouise A Keogh
Centre for Genetic Epidemiology, University of Melbourne, 723 Swanston Street, Carlton, Victoria 3053, Australia
Cancer Epidemiol Biomarkers Prev 13:2258-63. 2004.... - Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous AustraliansJohn H Stewart
Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia
Nephrology (Carlton) 9:247-52. 2004..CONCLUSION: For Australians born in the Pacific Island nations, Asia, the Middle East or Southern Europe, excess prevalence of, and/or susceptibility to, diseases that cause ESRD has more than offset any 'healthy migrant' effect... - Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancerJisheng S Cui
Centre for Genetic Epidemiology, The University of Melbourne, Melbourne, Victoria, Australia
Genet Epidemiol 24:161-72. 2003..This analytical approach is well-suited to the data that arise from population-based case-control-family studies, in which cases, controls and relatives are studied, and genotype is measured for some but not all subjects...